ArticleBMC bioinformatics2025
A parametric survival model with bayesian structural equation based on multi-omics integration.
Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundMulti-omics integration may provide additional information about the development of tumors and improve the performance of predictive models. The key challenge lies in integrating several omics sources, especially to capture their biological relationships. Previous studies proposed a structural equation model framework to combine two data platforms for predicting survival; however, several limitations remain.
resultsIn this study, we introduce an extended Bayesian survival model combined with a structural equation model for adaptation to broader applications. The No U-turn Sampling (NUTS) algorithm was utilized to efficiently sample the posterior distribution of model parameters. Through a series of simulation studies, our model showed excellent goodness-of-fit and predictive performance. To validate the efficiency of our model, we utilized a gastric cancer dataset with three omics types (mRNA, microRNA, and methylation) obtained from The Cancer Genome Atlas. After bioinformatic processing, we included six mRNA, microRNA, and methylation loci datasets into the framework and discovered that our model exhibited greater predictive performance compared to non-integrated and Integrative Bayesian Analysis of Genomics (iBAG) models.
conclusionsIn conclusion, our extended Bayesian structural equation model for multi-omics survival analysis provides a robust framework that significantly enhances predictive accuracy by effectively capturing complex biological relationships across diverse omics data sources, demonstrating clear advantages over both non-integrated approaches and existing integrative methods like iBAG.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.